Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             174 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absolute Bioavailability of Intranasal Fluticasone Furoate in Healthy Subjects Allen, Ann
2007
29 Supplement 2 p. 1415-1420
6 p.
artikel
2 Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus Kinsley, Brendan
2007
29 Supplement 2 p. S153-S160
8 p.
artikel
3 Acute Pancreatitis in a Patient Treated with Micafungin Sato, Ken
2007
29 Supplement 2 p. 1468-1473
6 p.
artikel
4 Adoption of new antiglaucoma drugs in finland: Impact of changes in copayment Martikainen, Jaana E.
2007
29 Supplement 2 p. 2468-2476
9 p.
artikel
5 A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin Rogers, Sophie L.
2007
29 Supplement 2 p. 242-252
11 p.
artikel
6 Advancing Therapy in Type 2 Diabetes Mellitus with Early, Comprehensive Progression from Oral Agents to Insulin Therapy Vinik, Aaron
2007
29 Supplement 2 p. 1236-1253
18 p.
artikel
7 Adverse drug interactions involving common prescription and over-the-counter analgesic agents Hersh, Elliot V.
2007
29 Supplement 2 p. 2477-2497
21 p.
artikel
8 A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets Lachaine, Jean
2007
29 Supplement 2 p. 519-528
10 p.
artikel
9 Analgesic efficacy of celecoxib in postoperative oral surgery pain: A single-dose, two-center, randomized, double-blind, active- and placebo-controlled study Cheung, Raymond
2007
29 Supplement 2 p. 2498-2510
13 p.
artikel
10 An Evaluation of patients' preferences for osteoporosis medications and their attributes: The PREFER-international study Duarte, Jesús Walliser
2007
29 Supplement 2 p. 488-503
16 p.
artikel
11 A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers Bladh, Nina
2007
29 Supplement 2 p. 640-649
10 p.
artikel
12 Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: A retrospective database study Yurgin, Nicole
2007
29 Supplement 2 p. 316-325
10 p.
artikel
13 A phase i, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults Swearingen, Dennis
2007
29 Supplement 2 p. 617-625
9 p.
artikel
14 A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain Moberly, James B.
2007
29 Supplement 2 p. 399-412
14 p.
artikel
15 A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis Breuer, Brenda
2007
29 Supplement 2 p. 2022-2030
9 p.
artikel
16 A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain Beaulieu, André D.
2007
29 Supplement 2 p. 49-60
12 p.
artikel
17 A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults Park, Kyungsoo
2007
29 Supplement 2 p. 154-162
9 p.
artikel
18 A Retrospective Evaluation of the Use of Gabapentin and Pregabalin in Patients with Postherpetic Neuralgia in Usual-Care Settings Gore, Mugdha
2007
29 Supplement 2 p. 1655-1670
16 p.
artikel
19 A review of combination therapy in patients with benign prostatic hyperplasia McVary, Kevin T.
2007
29 Supplement 2 p. 387-398
12 p.
artikel
20 A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostate Naslund, Michael J.
2007
29 Supplement 2 p. 17-25
9 p.
artikel
21 A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers Monif, Tausif
2007
29 Supplement 2 p. 2677-2684
8 p.
artikel
22 Assessing antibodies to α-galactosidase A in fabry disease Richards, Susan M.
2007
29 Supplement 2 p. S7-S8
2 p.
artikel
23 Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study Adachi, Jonathan D.
2007
29 Supplement 2 p. 2055-2067
13 p.
artikel
24 Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial Song, Yeong Wook
2007
29 Supplement 2 p. 862-873
artikel
25 A 2-Week, Crossover Study to Investigate the Effect of Fluticasone Furoate Nasal Spray on Short-Term Growth in Children with Allergic Rhinitis Gradman, Josefine
2007
29 Supplement 2 p. 1738-1747
10 p.
artikel
26 A 2-Week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain Choi, Chan-Bum
2007
29 Supplement 2 p. 1381-1389
9 p.
artikel
27 A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in african american and hispanic american patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy Davidson, Jaime A.
2007
29 Supplement 2 p. 1900-1914
15 p.
artikel
28 A 6-Week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004% Maul, Eugenio
2007
29 Supplement 2 p. 1915-1923
9 p.
artikel
29 A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler Murphy, Kevin
2007
29 Supplement 2 p. 1013-1026
14 p.
artikel
30 A 12-Week, Prospective, Open-Label Analysis of the Effect of Rosuvastatin on Triglyceride-Rich Lipoprotein Metabolism in Patients with Primary Dyslipidemia Kostapanos, Michael S.
2007
29 Supplement 2 p. 1403-1414
12 p.
artikel
31 A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL) Tytus, Richard H.
2007
29 Supplement 2 p. 305-315
11 p.
artikel
32 Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: A randomized, double-blind, 2-way crossover in healthy male thai volunteers Boonleang, Jutima
2007
29 Supplement 2 p. 703-710
8 p.
artikel
33 Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: Two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects Palma-Aguirre, Jose Antonio
2007
29 Supplement 2 p. 1146-1152
7 p.
artikel
34 Bioequivalence of Two Commercial Preparations of trimethoprim/sulfamethoxazole: A randomized, single-dose, single-blind, crossover trial Alonso Campero, Rosalba
2007
29 Supplement 2 p. 326-333
8 p.
artikel
35 Buprenorphine Transdermal Delivery System in Adults with Persistent Noncancer-Related Pain Syndromes Who Require Opioid Therapy: A Multicenter, 5-Week Run-in and Randomized, Double-Blind Maintenance-of-Analgesia Study Landau, Craig J.
2007
29 Supplement 2 p. 2179-2193
15 p.
artikel
36 Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial Nelson, Harold S.
2007
29 Supplement 2 p. 2167-2178
12 p.
artikel
37 Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: The role of comparative studies and implications for future studies Cosman, Felicia
2007
29 Supplement 2 p. 1116-1127
12 p.
artikel
38 Clinical perspectives in the prevention and treatment of chronic nephropathy, including an overview of the DEMAND Study Remuzzi, Giuseppe
2007
29 Supplement 2 p. S64-S72
9 p.
artikel
39 Clinical practice and guidelines in Europe for the treatment of hypertension, with a focus on patients with diabetes mellitus Zanchetti, Alberto
2007
29 Supplement 2 p. S44-S53
10 p.
artikel
40 Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: A 23-day, prospective, double-blind, randomized, parallel-group study Rodriguez, René Fernando
2007
29 Supplement 2 p. 581-587
7 p.
artikel
41 Comment by Alan Lyles, section editor 2007
29 Supplement 2 p. 384-
1 p.
artikel
42 Comorbidity of diabetes mellitus and hypertension in the clinical setting: A review of prevalence, pathophysiology, and treatment perspectives Bretzel, Reinhard G.
2007
29 Supplement 2 p. S35-S43
9 p.
artikel
43 Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: A 16-week, randomized, open-label, parallel-group trial conducted in russia Ushakova, Olga
2007
29 Supplement 2 p. 2374-2384
11 p.
artikel
44 Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia Chapman, Mary Ann
2007
29 Supplement 2 p. 1325-1337
13 p.
artikel
45 Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: A retrospective, nonrandomized, open-label, historical chart review Lorente, Leonardo
2007
29 Supplement 2 p. 2433-2439
7 p.
artikel
46 Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study Lewin, Andrew
2007
29 Supplement 2 p. 844-855
artikel
47 Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen Rascati, Karen L.
2007
29 Supplement 2 p. 1203-1213
11 p.
artikel
48 Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults Antonijoan, Rosa
2007
29 Supplement 2 p. 814-822
artikel
49 Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: An 8-week, multicenter, randomized, open-label, dose-titration study in korean patients with hypercholesterolemia Hak Lee, Sang
2007
29 Supplement 2 p. 2365-2373
9 p.
artikel
50 Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: A single-center, randomized, double-blind, two-period, crossover trial in Japan Hirao, Koichi
2007
29 Supplement 2 p. 927-934
artikel
51 Comparison of usability and patient preference for the new disposable insulin device solostar versus flexpen, lilly disposable pen, and a prototype pen: an open-label study Haak, Thomas
2007
29 Supplement 2 p. 650-660
11 p.
artikel
52 Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus Balkrishnan, Rajesh
2007
29 Supplement 2 p. 1306-1315
10 p.
artikel
53 Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: A European model based on the CLARITY and COMMIT trials Berg, Jenny
2007
29 Supplement 2 p. 1184-1202
19 p.
artikel
54 Cost-Effectiveness of Irbesartan 300 mg Given Early Versus Late in Patients with Hypertension and a History of Type 2 Diabetes and Renal Disease: A Canadian Perspective Coyle, Douglas
2007
29 Supplement 2 p. 1508-1523
16 p.
artikel
55 Darunavir: A Nonpeptidic Antiretroviral Protease Inhibitor McCoy, Christopher
2007
29 Supplement 2 p. 1559-1576
18 p.
artikel
56 Deferasirox for Transfusion-Related Iron Overload: A Clinical Review Lindsey, Wesley T.
2007
29 Supplement 2 p. 2154-2166
13 p.
artikel
57 Desloratadine treatment for intermittent and persistent allergic rhinitis: A review Bachert, Claus
2007
29 Supplement 2 p. 1795-1802
8 p.
artikel
58 Developing a Pulmonary Insulin Delivery System for Patients with Diabetes Dailey, George
2007
29 Supplement 2 p. 1271-1283
13 p.
artikel
59 Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg Schreiber, Curtis P.
2007
29 Supplement 2 p. 2511-2519
9 p.
artikel
60 Diffusion into Use of Exenatide for Glucose Control in Diabetes Mellitus: A Retrospective Cohort Study of a New Therapy Segal, Jodi B.
2007
29 Supplement 2 p. 1784-1794
11 p.
artikel
61 Does Statin Therapy Initiation Increase the Risk for Myopathy? An Observational Study of 32,225 Diabetic and Nondiabetic Patients Nichols, Gregory A.
2007
29 Supplement 2 p. 1761-1770
10 p.
artikel
62 Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study Nurko, Saul
2007
29 Supplement 2 p. 2010-2021
12 p.
artikel
63 Dosing of insulin glargine in the treatment of type 2 diabetes Barnett, Anthony
2007
29 Supplement 2 p. 987-999
13 p.
artikel
64 Editorial Board 2007
29 Supplement 2 p. CO2-
1 p.
artikel
65 Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: A meta-analysis of randomized controlled trials Kang, Sheng
2007
29 Supplement 2 p. 2406-2418
13 p.
artikel
66 Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial Keith, Paul K.
2007
29 Supplement 2 p. 419-426
8 p.
artikel
67 Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study Crisafulli, Ernesto
2007
29 Supplement 2 p. 2001-2009
9 p.
artikel
68 Effect of Miglustat on Bone Disease in Adults with Type 1 Gaucher Disease: A Pooled Analysis of Three Multinational, Open-Label Studies Pastores, Gregory M.
2007
29 Supplement 2 p. 1645-1654
10 p.
artikel
69 Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: A three-way crossover study Fogari, Roberto
2007
29 Supplement 2 p. 413-418
6 p.
artikel
70 Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: A randomized, open-label, crossover study in taiwan Tsai, Yuh-Shyan
2007
29 Supplement 2 p. 670-682
13 p.
artikel
71 Effects of Milrinone on Contractility and Cyclic Adenosine Monophosphate Production Induced by β1- and β2-Adrenergic Receptor Activation in Human Myocardium Carceles, Mafía D.
2007
29 Supplement 2 p. 1718-1724
7 p.
artikel
72 Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: A double-blind, randomized, parallel-group study Graff, Jochen
2007
29 Supplement 2 p. 438-447
10 p.
artikel
73 Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: A prospective, nonrandomized, crossover study in patients coinfected with hepatitis c and hiv receiving methadone maintenance treatment Berk, Steven I.
2007
29 Supplement 2 p. 131-138
8 p.
artikel
74 Effects of renin-angiotensin system inhibition end-organ protection: Can we do better? Weir, Matthew R.
2007
29 Supplement 2 p. 1803-1824
22 p.
artikel
75 Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial Välimäiki, Matti J.
2007
29 Supplement 2 p. 1937-1949
13 p.
artikel
76 Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial LaForce, Craig
2007
29 Supplement 2 p. 1579-1590
12 p.
artikel
77 Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: A 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study Pytel, Joseph
2007
29 Supplement 2 p. 84-98
15 p.
artikel
78 Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients Yevtushenko, Valery Y.
2007
29 Supplement 2 p. 2319-2332
14 p.
artikel
79 Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease Besarab, Anatole
2007
29 Supplement 2 p. 626-639
14 p.
artikel
80 Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis Hale, Martin
2007
29 Supplement 2 p. 874-888
artikel
81 Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, double-blind, active- and placebo-controlled, parallel-group trial Aqua, Keith
2007
29 Supplement 2 p. 1000-1012
13 p.
artikel
82 Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study Gibofsky, Allan
2007
29 Supplement 2 p. 1071-1085
15 p.
artikel
83 Efficacy of Multivitamin Supplementation Containing Vitamins B6 and B12 and Folic Acid as Adjunctive Treatment with a Cholinesterase Inhibitor in Alzheimer's Disease: A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study in Taiwanese Patients Sun, Yu
2007
29 Supplement 2 p. 2204-2214
11 p.
artikel
84 Efficacy of oral nicorandil in patients with end-stage renal disease: A retrospective chart review after coronary angioplasty in japanese patients receiving hemodialysis Ishii, Hideki
2007
29 Supplement 2 p. 110-122
13 p.
artikel
85 Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: A randomized, double-blind, placebo-controlled study Ishkanian, Gary
2007
29 Supplement 2 p. 99-109
11 p.
artikel
86 Empiric therapy for secondary peritonitis: A pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation Eagye, Kathryn J.
2007
29 Supplement 2 p. 889-899
artikel
87 Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin a microemulsion: A randomized, open-label, two-period crossover study in healthy adult male mexican volunteers Piñeyro-López, Alfredo
2007
29 Supplement 2 p. 2049-2054
6 p.
artikel
88 Evidence-Based Pharmacologic Management of Pulmonary Arterial Hypertension Benedict, Neal
2007
29 Supplement 2 p. 2134-2153
20 p.
artikel
89 Evidence for selective low leukocyte enzyme activity levels associated with the G1170C>T 5'untranslated polymorphism of the α-galactosidase a gene Ferreira, S.
2007
29 Supplement 2 p. S28-S29
2 p.
artikel
90 Fabry disease model: A rational approach to the management of fabry disease Wanner, Christoph
2007
29 Supplement 2 p. S2-S5
4 p.
artikel
91 Factors related to antipsychotic oversupply among central Texas Veterans Yang, Min
2007
29 Supplement 2 p. 1214-1225
12 p.
artikel
92 Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study Simpson, David M.
2007
29 Supplement 2 p. 588-601
14 p.
artikel
93 Formation of neutralizing antibodies in patients receiving botulinum toxin type a for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials Yablon, Stuart A.
2007
29 Supplement 2 p. 683-690
8 p.
artikel
94 Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis Schwid, Steven R.
2007
29 Supplement 2 p. 2031-2048
18 p.
artikel
95 Getting closer to physiologic insulin secretion Heise, Tim
2007
29 Supplement 2 p. S161-S165
5 p.
artikel
96 Goserelin Acetate 10.8 mg Plus Iron Versus Iron Monotherapy Prior to Surgery in Premenopausal Women with Iron-Deficiency Anemia Due to Uterine Leiomyomas: Results from a Phase III, Randomized, Multicenter, Double-Blind, Controlled Trial Muneyyirci-Delale, Ozgul
2007
29 Supplement 2 p. 1682-1691
10 p.
artikel
97 Health Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database Analysis Pawaskar, Manjiri D.
2007
29 Supplement 2 p. 1294-1305
12 p.
artikel
98 Heart failure patients' awareness and perceptions of the risk of using NSAIDs: A pilot study Cottrell, Neil
2007
29 Supplement 2 p. 717-719
3 p.
artikel
99 Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: Case report and review of the literature Mohammadianpanah, Mohammad
2007
29 Supplement 2 p. 1161-1165
5 p.
artikel
100 Hypertension treatment in a medicare population: Adherence and systolic blood pressure control Fung, Vicki
2007
29 Supplement 2 p. 972-984
artikel
101 Hypertriglyceridemia and cardiovascular risk reduction Jacobson, Terry A.
2007
29 Supplement 2 p. 763-777
artikel
102 Hypertrophic Cardiomyopathy in Anderson-Fabry Disease Cecchi, Franco
2007
29 Supplement 2 p. S93-S94
2 p.
artikel
103 Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis Giovannoni, Gavin
2007
29 Supplement 2 p. 1128-1145
18 p.
artikel
104 Importance of Observational Studies in Clinical Practice Ligthelm, Robert J.
2007
29 Supplement 2 p. 1284-1292
9 p.
artikel
105 Influence of Antiretroviral Therapy on Oxidative Stress and Cardiovascular Risk: A Prospective Cross-Sectional Study in HIV-Infected Patients Masiá, Mar
2007
29 Supplement 2 p. 1448-1455
8 p.
artikel
106 Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: A single-dose, randomized, open-label, two-way crossover study Solans, Anna
2007
29 Supplement 2 p. 900-908
artikel
107 Inhaled dry powder insulin for the treatment of diabetes mellitus Setter, Stephen M.
2007
29 Supplement 2 p. 795-813
artikel
108 Interaction Between Warfarin and Cranberry Juice Paeng, Christine H.
2007
29 Supplement 2 p. 1730-1735
6 p.
artikel
109 Management of access to branded psychotropic medications in private health plans Hodgkin, Dominic
2007
29 Supplement 2 p. 371-380
10 p.
artikel
110 Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison Robbins, David C.
2007
29 Supplement 2 p. 2349-2364
16 p.
artikel
111 Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial Derosa, Giuseppe
2007
29 Supplement 2 p. 602-610
9 p.
artikel
112 Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials Buse, John B.
2007
29 Supplement 2 p. 139-153
15 p.
artikel
113 Narcotic Drug Use Among Patients with Lower Back Pain in Employer Health Plans: A Retrospective Analysis of Risk Factors and Health Care Services Rhee, YongJoo
2007
29 Supplement 2 p. 2603-2612
10 p.
artikel
114 Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial Baumgartner, Rudolf A.
2007
29 Supplement 2 p. 261-278
18 p.
artikel
115 Negative Binomial Meta-Regression Analysis of Combined Glycosylated Hemoglobin and Hypoglycemia Outcomes Across Eleven Phase III and IV Studies of Insulin Glargine Compared with Neutral Protamine Hagedorn Insulin in Type 1 and Type 2 Diabetes Mellitus Mullins, Peter
2007
29 Supplement 2 p. 1607-1619
13 p.
artikel
116 Nelarabine: A novel purine antimetabolite antineoplastic agent Buie, Larry W.
2007
29 Supplement 2 p. 1887-1899
13 p.
artikel
117 Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: A retrospective analysis of a randomized, double-blind, double-dummy trial Marple, Bradley F.
2007
29 Supplement 2 p. 2690-2698
9 p.
artikel
118 Optimizing Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Strategies for Improving Patient-Centered Outcomes Hanania, Nicola A.
2007
29 Supplement 2 p. 2121-2133
13 p.
artikel
119 Oral Garenoxacin in the Treatment of Acute Bacterial Maxillary Sinusitis: A Phase II, Multicenter, Noncomparative, Open-Label Study in Adult Patients Undergoing Sinus Aspiration Lopez Sisniega, J.
2007
29 Supplement 2 p. 1632-1644
13 p.
artikel
120 Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial Rog, David J.
2007
29 Supplement 2 p. 2068-2079
12 p.
artikel
121 Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus Chao, Jingdong
2007
29 Supplement 2 p. 177-180
4 p.
artikel
122 Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects O'Farrell, A. Marie
2007
29 Supplement 2 p. 1692-1705
14 p.
artikel
123 Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate: A phase I, randomized, open-label, increasing-dose study in healthy chinese men Li, Yishi
2007
29 Supplement 2 p. 1957-1966
10 p.
artikel
124 Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Escher, Monica
2007
29 Supplement 2 p. 1620-1631
12 p.
artikel
125 Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study Li, Yunxia
2007
29 Supplement 2 p. 2194-2203
10 p.
artikel
126 Pharmacokinetics and Pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease Smith, William B.
2007
29 Supplement 2 p. 1368-1380
13 p.
artikel
127 Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: An open-label, single- and multiple-dose study James, Laura
2007
29 Supplement 2 p. 2082-2092
11 p.
artikel
128 Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage Kikuchi, Junko
2007
29 Supplement 2 p. 123-130
8 p.
artikel
129 Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years Kisicki, James C.
2007
29 Supplement 2 p. 1967-1979
13 p.
artikel
130 Plasma Pharmacokinetic Characteristics of Risperidone and Their Relationship to Saliva Concentrations in Children with Psychiatric or Neurodevelopmental Disorders Aman, Michael G.
2007
29 Supplement 2 p. 1476-1486
11 p.
artikel
131 Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children Rahman, Ateequr
2007
29 Supplement 2 p. 1950-1956
7 p.
artikel
132 Posaconazole: An extended-spectrum triazole antifungal agent Schiller, Daryl S.
2007
29 Supplement 2 p. 1862-1886
25 p.
artikel
133 Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus Singh-Franco, Devada
2007
29 Supplement 2 p. 535-562
28 p.
artikel
134 Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison Ilag, Liza L.
2007
29 Supplement 2 p. 1254-1270
17 p.
artikel
135 Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders Tassone, Daniel M.
2007
29 Supplement 2 p. 26-48
23 p.
artikel
136 Prescript-assist™ probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial Bittner, Alvah C.
2007
29 Supplement 2 p. 1153-1160
8 p.
artikel
137 Prevalence and treatment of dyslipidemia in canadian primary care: A retrospective cohort analysis Petrella, Robert J.
2007
29 Supplement 2 p. 742-750
9 p.
artikel
138 Prevalence of fabry disease in a cohortof 479 unrelated patients with hypertrophic cardiomyopathy Monserrat, L.
2007
29 Supplement 2 p. S23-S24
2 p.
artikel
139 Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid Population, 1998–2003 Morrato, Elaine H.
2007
29 Supplement 2 p. 183-195
13 p.
artikel
140 Progression of fabry cardiomyopathy Strotmann, Jörg
2007
29 Supplement 2 p. S13-S14
2 p.
artikel
141 Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia Cappellini, Maria Domenica
2007
29 Supplement 2 p. 909-917
artikel
142 Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy Tisdale, James E.
2007
29 Supplement 2 p. 2226-2234
9 p.
artikel
143 Proton pump inhibitors and hospital discharge rates for gastrointestinal events in italy: A national ecological study Russo, Pierluigi
2007
29 Supplement 2 p. 751-758
8 p.
artikel
144 Ranibizumab for the treatment of neovascular age-related macular degeneration: A review Kourlas, Helen
2007
29 Supplement 2 p. 1850-1861
12 p.
artikel
145 Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: A summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability Thyssen, An
2007
29 Supplement 2 p. 290-304
15 p.
artikel
146 Rationale for use of the fixed combination of delapril and manidipine in the treatment of hypertension in patients with diabetes mellitus Fogari, Roberto
2007
29 Supplement 2 p. S54-S63
10 p.
artikel
147 Reducing the Risk for Breast Cancer Recurrence After Completion of Tamoxifen Treatment in Postmenopausal Women Jahanzeb, Mohammad
2007
29 Supplement 2 p. 1535-1547
13 p.
artikel
148 Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: A single-dose, randomized, open-label, crossover study in healthy subjects Henney III, Herbert R.
2007
29 Supplement 2 p. 661-669
9 p.
artikel
149 Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension Sharma, Akhilesh
2007
29 Supplement 2 p. 2667-2676
10 p.
artikel
150 Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in korean adults with mild to moderate hypertension Kim, Sang-Hyun
2007
29 Supplement 2 p. 1924-1936
13 p.
artikel
151 Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes Zieve, Franklin J.
2007
29 Supplement 2 p. 74-83
10 p.
artikel
152 RETRACTED: Prevention of pain due to injection of propofol with IV administration of lidocaine 40 mg + metoclopramide 2.5, 5, or 10 mg or saline: A randomized, double-blind study in Japanese adult surgical patients Fujii, Yoshitaka
2007
29 Supplement 2 p. 856-861
artikel
153 Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: A pooled analysis of thirty clinical trials Winkler, Karl
2007
29 Supplement 2 p. 1987-2000
14 p.
artikel
154 Role of patient experience in atypical antipsychotic adherence: A retrospective data analysis Vanelli, Mark
2007
29 Supplement 2 p. 2768-2773
6 p.
artikel
155 Simulated Comparison of the Pharmacodynamics of Ciprofloxacin and Levofloxacin Against Pseudomonas aeruginosa Using Pharmacokinetic Data from Healthy Volunteers and 2002 Minimum Inhibitory Concentration Data Burgess, David S.
2007
29 Supplement 2 p. 1421-1427
7 p.
artikel
156 Single-Dose Intravenous Tramadol for Acute Migraine Pain in Adults: A Single-Blind, Prospective, Randomized, Placebo-Controlled Clinical Trial Alemdar, Murat
2007
29 Supplement 2 p. 1441-1447
7 p.
artikel
157 Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus Zerilli, Tina
2007
29 Supplement 2 p. 2614-2634
21 p.
artikel
158 Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: Results of two randomized studies in patients with Parkinson's disease Tompson, Debra J.
2007
29 Supplement 2 p. 2654-2666
13 p.
artikel
159 Sunitinib Malate for the Treatment of Metastatic Renal Cell Carcinoma and Gastrointestinal Stromal Tumors Adams, Val R.
2007
29 Supplement 2 p. 1338-1353
16 p.
artikel
160 Telbivudine for the management of chronic hepatitis B virus infection Matthews, S. James
2007
29 Supplement 2 p. 2635-2653
19 p.
artikel
161 The effects of combination treatment with a long-acting β2-agonist and a corticosteroid on salivary flow rate, secretory immunoglobulin a, and oral health in children and adolescents with moderate asthma: a 1-month, single-blind clinical study Sag, Cigdem
2007
29 Supplement 2 p. 2236-2242
7 p.
artikel
162 The long-term effect of enzyme replacement therapy on regression of left ventricular hypertrophy in patients with Fabry cardiomyopathy. Impact of baseline findings Strotmann, J.
2007
29 Supplement 2 p. S30-
1 p.
artikel
163 Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance Luna, Beatriz
2007
29 Supplement 2 p. 2309-2318
10 p.
artikel
164 Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension Poldermans, Don
2007
29 Supplement 2 p. 279-289
11 p.
artikel
165 Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial Barnett, Anthony H.
2007
29 Supplement 2 p. 2333-2348
16 p.
artikel
166 Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study Cowie, Robert L.
2007
29 Supplement 2 p. 1390-1402
13 p.
artikel
167 Topiramate prescribing patterns among medicaid patients: Diagnosis, comorbidities, and dosing Poston, Sara
2007
29 Supplement 2 p. 504-518
15 p.
artikel
168 Transdermal Buprenorphine Patches Applied in a 4-Day Regimen Versus a 3-Day Regimen: A Single-Site, Phase III, Randomized, Open-Label, Crossover Comparison Likar, Rudolf
2007
29 Supplement 2 p. 1591-1606
16 p.
artikel
169 Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder—A preliminary tolerability and efficacy study Quintana, Humberto
2007
29 Supplement 2 p. 1168-1177
10 p.
artikel
170 Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: A 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial Berger, Richard
2007
29 Supplement 2 p. 1086-1097
12 p.
artikel
171 Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma Corren, Jonathan
2007
29 Supplement 2 p. 823-843
artikel
172 Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension Philipp, Thomas
2007
29 Supplement 2 p. 563-580
18 p.
artikel
173 Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: Insulin pump therapy versus multiple daily injections Bode, Bruce W.
2007
29 Supplement 2 p. S135-S144
10 p.
artikel
174 Utilization of, and Adherence to, Drug Therapy Among Medicaid Beneficiaries with Congestive Heart Failure Bagchi, Ann D.
2007
29 Supplement 2 p. 1771-1783
13 p.
artikel
                             174 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland